Holdings
Omega Fund Management, LLC
As of Jun 30, 2026, Omega Fund Management, LLC reported 10 positions worth US$186M. Largest: Bicara Therapeutics Inc., Nuvation Bio Inc. and Kestra Medical Technologies, Ltd. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Bicara Therapeutics Inc. | 1.82M | US$54.1M | −570K | Jun 30, 2026 |
| Nuvation Bio Inc. | 8.08M | US$45.9M | no change | Jun 30, 2026 |
| Kestra Medical Technologies, Ltd. | 1.02M | US$26M | no change | Jun 30, 2026 |
| Bridgebio Oncology Therapeutics, Inc. | 3.29M | US$25.1M | no change | Jun 30, 2026 |
| Beta Bionics, Inc. | 1.32M | US$20.6M | no change | Jun 30, 2026 |
| Alumis Inc. | 241K | US$6.79M | no change | Jun 30, 2026 |
| Sana Biotechnology, Inc. | 844K | US$2.94M | no change | Jun 30, 2026 |
| Imagenebio, Inc. | 455K | US$2.69M | no change | Jun 30, 2026 |
| Engene Holdings Inc. | 876K | US$1.52M | no change | Jun 30, 2026 |
| Odyssey Therapeutics, Inc. | 2,893 | US$54,128 | new | Jun 30, 2026 |